deltatrials
Terminated PHASE3 INTERVENTIONAL NCT00000361

Autoimmunity in Inner Ear Disease

Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions Hearing Loss, Sensorineural
Interventions Corticosteroids Methotrexate
Updated 5 times since 2017 Last updated: Apr 21, 2006 Started: Mar 31, 1998 Completion: Nov 30, 2002
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from National Institute on Deafness and Other Communication Disorders (NIDCD)

See all terminations from National Institute on Deafness and Other Communication Disorders (NIDCD)

Other Hearing Loss, Sensorineural trials with similar outcome

Browse all Hearing Loss, Sensorineural trials

A PHASE3 clinical study on Hearing Loss, Sensorineural, this trial is terminated or withdrawn. The trial is conducted by National Institute on Deafness and Other Communication Disorders (NIDCD) and has accumulated 5 data snapshots since 1998. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Mar 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute on Deafness and Other Communication Disorders (NIDCD)
Data source: National Institute on Deafness and Other Communication Disorders (NIDCD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations